Company · Ownership research

Vera Therapeutics, Inc. VERA

CIK 0001831828

Form 4 transactions dated Sep 1, 2023 to Sep 25, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 37 rows; the complete set is available through the API.

Insider filings on file run through 2026-09-04.

Insider purchases & sales

Purchased: $10.53M
Sold: $79.55M

Sep 1, 2023 – Sep 4, 2026
Available records · partial months are marked ·

Insiders in this window

202610 of 12 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
2026-09-02	Fordyce Marshall PRESIDENT AND CEO · Director	Sale10b5-1 footnote	$649.64K 18,500 shares sold	7.29% sold Direct holding	▾
2026-07-07	Fordyce Marshall PRESIDENT AND CEO · Director	Sale10b5-1 footnote	$1.96M 46,250 shares sold	16.43% sold Direct holding	▾
2026-06-23	Fordyce Marshall PRESIDENT AND CEO · Director	Sale10b5-1 footnote	$701.77K 18,500 shares sold	7.29% sold Direct holding	▾
2026-05-12	Fordyce Marshall PRESIDENT AND CEO · Director	Sale10b5-1 footnote	$679.75K 18,500 shares sold	7.29% sold Direct holding	▾
2026-04-14	Fordyce Marshall PRESIDENT AND CEO · Director	Sale10b5-1 footnote	$1.01M 22,951 shares sold	8.89% sold Direct holding	▾
2026-02-23	Skelton Laurence Matthew Chief Commercial Officer	Sale	$66.42K 1,582 shares sold	2.40% sold Direct holding	▾
2026-02-23	Brenner Robert Chief Medical Officer	Sale	$90.31K 2,151 shares sold	4.05% sold Direct holding	▾
2026-02-23	Grant Sean CHIEF FINANCIAL OFFICER	Sale	$207.78K 4,949 shares sold	4.15% sold Direct holding	▾
2026-02-23	Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR	Sale	$130.86K 3,117 shares sold	4.59% sold Direct holding	▾
2026-02-23	Fordyce Marshall PRESIDENT AND CEO · Director	Sale	$710.58K 16,925 shares sold	6.18% sold Direct holding	▾

Showing 12 / 12 record groups in 2026. The complete set is available through the API.

Vera Therapeutics, Inc. · VERA

Follow the people behind the trades.

Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 12 of 12 purchase / sale groups and 30 of 37 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

list_insider_transactions
{"ticker":"VERA","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.